The tumor promoting effect of PRDX2 was demonstrated in colorectal carcinoma through up-regulation of Wnt/β-catenin pathway [50], and prostate cancer through increased activation of the androgen receptor (AR) signaling pathway [51]. Here, AR is linked to prostate cancer.